These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2868472)

  • 1. Ocular changes and phenothiazine derivatives in long-term residents of a mental retardation center.
    Gowdey CW; Coleman LM; Crawford EM
    Psychiatr J Univ Ott; 1985 Dec; 10(4):248-53. PubMed ID: 2868472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Corneal and lens deposits due to treatment by phenothiazine type neuroleptics].
    Pouget R; Blayac JP; Largey B; Alric R; Castelnau D; Boulet J
    Ann Med Psychol (Paris); 1976 Mar; 1(3):403-7. PubMed ID: 7987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular change and phenothiazine therapy.
    Cummings P; Lidahl LL
    Am Fam Physician; 1985 May; 31(5):23. PubMed ID: 2859771
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome and mental retardation: review and analysis of 29 cases.
    Boyd RD
    Am J Ment Retard; 1993 Jul; 98(1):143-55. PubMed ID: 8103996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior lens opacities in prolonged phenothiazine therapy.
    Hesse RJ
    Ann Ophthalmol; 1979 Aug; 11(8):1212. PubMed ID: 45370
    [No Abstract]   [Full Text] [Related]  

  • 7. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular pigmentation and phenothiazine derivatives].
    Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F
    Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dangers of corticoid therapy in ophthalmology].
    Himmat HW
    Rev Med Moyen Orient; 1967; 24(4):360-2. PubMed ID: 5269289
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptics in mentally retarded children].
    Höllge J
    Cesk Pediatr; 1993 Sep; 48(9):547-9. PubMed ID: 7902782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactive drug treatment in retarded populations.
    Psychopharmacol Bull; 1982 Jan; 18(1):50-66. PubMed ID: 6124020
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular changes associated with long term phenothiazine usage.
    Alexander TA; John JK; Thomas A; Verghese A
    Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036
    [No Abstract]   [Full Text] [Related]  

  • 15. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cataract occurrence with antipsychotic drugs.
    Shahzad S; Suleman MI; Shahab H; Mazour I; Kaur A; Rudzinskiy P; Lippmann S
    Psychosomatics; 2002; 43(5):354-9. PubMed ID: 12297603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mental handicap].
    Hebebrand J; Hässler F
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):301. PubMed ID: 20306790
    [No Abstract]   [Full Text] [Related]  

  • 18. Lenticular deposits associated with chloroquine Keratopathy.
    Lal S; Gupta AK
    Indian J Ophthalmol; 1974 Jun; 22(2):34-5. PubMed ID: 4461692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eye complications in the long-term treatment with chloroquin. Study carried out in Togo].
    Trojan HJ
    Rev Int Trach Pathol Ocul Trop Subtrop; 1975; 52(3-4):129-37. PubMed ID: 1232656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.